| 18 years and more
- | Country :
- France
- | organs :
- Prostate
- | Specialty :
- Thérapies Ciblées
Extract
Phase II study of dasatinib (BMS-354825) for androgen-deprived progressive prostate cancer.
Scientific Abstract
en cours d'intégration;
Phase II study of dasatinib (BMS-354825) for androgen-deprived progressive prostate cancer.
en cours d'intégration;